Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 766 AL 780

The Development of Pathways in Palliative Medicine: Definition, Models, Cost and Quality Impact

Finn L, Malhotra S.

Healthcare (Basel). 2019 Feb 1;7(1):22. doi: 10.3390/healthcare7010022.

Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease?

Vilaça-Faria H, Salgado AJ, Teixeira FG.

Cells. 2019 Feb 2;8(2):118. doi: 10.3390/cells8020118.

Affective modulation of the associative-limbic subthalamic nucleus: deep brain stimulation in obsessive-compulsive disorder

Polosan M, Droux F, Kibleur A, Chabardes S, Bougerol T, David O, Krack P, Voon V.

Transl Psychiatry. 2019 Feb 4;9(1):73. doi: 10.1038/s41398-019-0404-y.

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Dos Santos Ghilardi MG, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK, Barbe MT, Ashkan K, Silverdale M, Evans J, Odin P, Fonoff ET, Fink GR, Henriksen T, Ebersbach G, Pirtošek Z, Visser-Vandewalle V, Antonini A, Timmermann L, Ray Chaudhuri K; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4.

Moving forward the in vivo diagnosis of the synucleinopathies

Vilas D.

Clin Auton Res. 2019 Dec;29(6):575-576. doi: 10.1007/s10286-019-00595-y. Epub 2019 Feb 5.

Retinal α-synuclein deposits in Parkinson's disease patients and animal models

Veys L, Vandenabeele M, Ortuño-Lizarán I, Baekelandt V, Cuenca N, Moons L, De Groef L.

Acta Neuropathol. 2019 Mar;137(3):379-395. doi: 10.1007/s00401-018-01956-z. Epub 2019 Feb 5.

The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease

Duyckaerts C, Clavaguera F, Potier MC.

Curr Opin Neurol. 2019 Apr;32(2):266-271. doi: 10.1097/WCO.0000000000000672.

Management of delirium in Parkinson's disease

Ebersbach G, Ip CW, Klebe S, Koschel J, Lorenzl S, Schrader C, Winkler C, Franke C.

J Neural Transm (Vienna). 2019 Jul;126(7):905-912. doi: 10.1007/s00702-019-01980-7. Epub 2019 Feb 6.

Amino acid profiling as a method of discovering biomarkers for diagnosis of neurodegenerative diseases

Socha E, Koba M, Kośliński P.

Amino Acids. 2019 Mar;51(3):367-371. doi: 10.1007/s00726-019-02705-6. Epub 2019 Feb 6.

Emerging links between pediatric lysosomal storage diseases and adult parkinsonism

Ysselstein D, Shulman JM, Krainc D.

Mov Disord. 2019 May;34(5):614-624. doi: 10.1002/mds.27631. Epub 2019 Feb 6.

Association between Hypertension and the Risk of Parkinson's Disease: A Meta-Analysis of Analytical Studies

Chen J, Zhang C, Wu Y, Zhang D.

Neuroepidemiology. 2019;52(3-4):181-192. doi: 10.1159/000496977. Epub 2019 Feb 6.

Antioxidants: Scientific Literature Landscape Analysis

Yeung AWK, Tzvetkov NT, El-Tawil OS, Bungǎu SG, Abdel-Daim MM, Atanasov AG.

Oxid Med Cell Longev. 2019 Jan 8;2019:8278454. doi: 10.1155/2019/8278454. eCollection 2019.

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

Pérez-Lloret S, Quarracino C, Otero-Losada M, Rascol O.

Expert Opin Pharmacother. 2019 Apr;20(6):635-645. doi: 10.1080/14656566.2019.1574746. Epub 2019 Feb 7.

The proteostasis network and its decline in ageing

Hipp MS, Kasturi P, Hartl FU.

Nat Rev Mol Cell Biol. 2019 Jul;20(7):421-435. doi: 10.1038/s41580-019-0101-y.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias